MindMaze Therapeutics Holding SA (V6M) Ownership - Who Owns MindMaze Therapeutics Holding SA?
MindMaze Therapeutics Holding SA (V6M) Ownership Overview
- <0.01% Other Institutional Investors
- 0.33% ETFs
- 99.67% Public Companies and Individual Investors
The ownership structure of MindMaze Therapeutics Holding SA (DE:V6M) stock is a mix of institutional, retail, and individual investors. Approximately 0.33% of the company’s stock is owned by Institutional Investors, and 99.67% is owned by Public Companies and Individual Investors.
The ownership structure of MindMaze Therapeutics Holding SA (DE:V6M) stock is a mix of institutional, retail, and individual investors. Approximately 0.33% of the company’s stock is owned by Institutional Investors, and 99.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 16, 2026 | Unnamed Swiss Director (n) | CHF10,140 | |
| Feb 08, 2026 | Unnamed Swiss Director (n) | CHF398,088 | |
| Feb 08, 2026 | Unnamed Swiss Director (n) | CHF220,028 | |
| Dec 18, 2025 | Unnamed Swiss Director (n) | CHF697,777 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ubs | 323,526 | Institution | 0.18% | 62,764 |
| Ishares | 269,661 | Institution | 0.15% | 52,314 |
FAQ
What percentage of MindMaze Therapeutics Holding SA (DE:V6M) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.33% of MindMaze Therapeutics Holding SA (DE:V6M) stock is held by institutional investors: 0.33% by ETFs and <0.01% by other institutional investors.
What percentage of MindMaze Therapeutics Holding SA (DE:V6M) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.67% of MindMaze Therapeutics Holding SA (DE:V6M) stock is held by public companies and individual investors.
Who owns the most shares of MindMaze Therapeutics Holding SA (DE:V6M)?
UBS owns the most shares of MindMaze Therapeutics Holding SA (DE:V6M).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.